Improving life for cancer patients through transformative drugs

Play

News

2018/05/18

Additional remetinostat phase II data will be presented at the International Investigative Dermatology meeting on May 18 and 19

Read more
2018/05/03

Resolutions at the Annual General Meeting in Medivir on 3 May 2018

Read more
2018/04/30

Number of shares and votes in Medivir

Read more

Partner with Medivir

Partnering is an important element of our business strategy. Together with our partners we have been successful in taking two products from research, through clinical development to launch on a global scale.